Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate.
Kantarjian HM, O'Brien S, Cortes JE, Smith TL, Rios MB, Shan J, Yang Y, Giles FJ, Thomas DA, Faderl S, Garcia-Manero G, Jeha S, Wierda W, Issa JP, Kornblau SM, Keating M, Resta D, Capdeville R, Talpaz M.
Kantarjian HM, et al. Among authors: cortes je.
Clin Cancer Res. 2002 Jul;8(7):2167-76.
Clin Cancer Res. 2002.
PMID: 12114417
Clinical Trial.